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Objectives The aim of this study was to test the hypothesis that moderate procedural sedation can
reduce the incidence of radial artery spasm.
Background Transradial access for left heart catheterization and percutaneous coronary intervention
is increasingly used for emergent and elective procedures, in lieu of the femoral approach. However,
increased rates of access site crossover have been reported, with radial artery spasm being a major
contributor to this effect.
Methods Patients undergoing elective transradial percutaneous coronary intervention were pro-
spectively randomized to receive fentanyl and midazolam during the procedure or no treatment
(control subjects). The primary endpoint was angiographically conﬁrmed radial artery spasm. Patient
discomfort was quantiﬁed with a visual analogue scale.
Results Two thousand thirteen patients (age 64.5  8.4 years) were randomized. Spasm occurred
in 2.6% of the treatment group versus 8.3% of control subjects (p  0.001; odds ratio [OR]: 0.29).
The number needed to treat to avoid 1 case of spasm was 18 (95% conﬁdence interval [CI]: 12.9 to
26.6). The access site crossover rate was 34% lower in the treatment group: 9.9% versus 15.0%
(OR: 0.62; 95% CI: 0.48 to 0.82). Patient discomfort visual analogue scale score was 18.8  12.5 in
the treatment group versus 27.4  17.4 in control subjects (p  0.001). No signiﬁcant differences
were observed in the 30-day rate of death or repeat hospital stay for any cause: 4.6% versus 4.5%
(OR: 1.02; 95% CI: 0.67 to 1.56).
Conclusions Routine administration of relatively low doses of an opioid/benzodiazepine combina-
tion during transradial interventional procedures is associated with a substantial reduction in the
rate of spasm, the need for access site crossover, and the procedure-related level of patient
discomfort. (J Am Coll Cardiol Intv 2013;6:267–73) © 2013 by the American College of Cardiology
Foundation
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268Transradial arterial access for performing diagnostic coro-
nary angiography and percutaneous coronary interventions
(PCI) has emerged over the last few years as a preferred
catheterization practice, on the basis of evidence that it is
associated with less vascular complications and shorter
hospital stays (1–4) as well as better outcomes in certain
high-risk patient subsets, such as patients with acute coro-
nary syndromes (5,6).
One of the problems with the transradial approach is that
access site crossover seems to be more frequent when the
initial route is the transradial one (3). The need to transfer
to an alternate access route is often the result of severe
arterial spasm leading to inability to further advance guide-
wires and catheters through the radial artery. Access site
crossover not only increases the procedure duration and
complexity but also seems to be an important predictor of
major vascular complications (1). Several preventive mea-
sures are being used to prevent radial artery spasm, including
nitrates and verapamil. Sedation has been suggested as a means
to reduce the incidence of spasm, but there is currently no
evidence base for the routine use of sedation or opioid analgesia
in transradial PCI. Systematic intravenous sedation and anal-
gesia, although widely applied in
some countries, including the
United States, is not a universal
practice in several parts of the
world. In addition, the potential
of an intravenous combination of
moderate doses of an opioid and a
sedative to reduce radial artery
spasm has never been tested in the
transradial PCI setting (7).
In the present study, we sought to test the hypothesis that
outine administration of sedation and opioid analgesia at
he beginning of transradial PCI would reduce the incidence
f arterial spasm.
ethods
This was a prospective randomized open-label study con-
ducted from January 2010 to February 2012 in 3 referral
hospitals in Greece. All subjects provided informed consent,
and the study was approved by the institutional review
boards. The study population consisted of prospectively
recruited patients undergoing PCI with transradial access.
Patients with an acute coronary syndrome within the
previous 2 weeks, cardiogenic shock, end-stage renal dis-
ease, severe hepatic impairment (Child-Pugh class C),
chronic opioid or benzodiazepine use, known peripheral
artery disease of the upper limbs, or a history of coronary
artery bypass grafting with both internal thoracic arteries
were excluded. Subjects with known hypersensitivity or
history of adverse reactions to benzodiazepines or opioids
Abbreviations
and Acronyms
CI  confidence interval
OR  odds ratio
PCI  percutaneous
coronary intervention
VAS  visual analogue scalewere also excluded.Patients were randomized to either administration of
sedation and analgesia (treatment group) or no intra-
procedural sedative/analgesic treatment (control subjects).
In the treatment group, fentanyl 0.5 g/kg and midazolam
mg slow intravenous push over 2 min were administered
t the beginning of the procedure (during preparation of the
ccess site). One additional dose was allowed 45 to 60 min
fter the first one (additional dosing according to the
edation status of the patient was not allowed, because
chieving “conscious sedation” status was not a requisite).
he respiration and oxygen saturation of the patient were
onstantly monitored by a dedicated interventional trained
urse.
The PCI was performed by experienced operators (at
east 100 transradial PCI procedures/year), who use the
ransradial route as default arterial access for coronary
atheterization. The right radial artery was cannulated as
efault, except in cases with previous bypass surgery with
se of the left internal thoracic artery, where the left radial
rtery was catheterized. Local anesthesia (subcutaneous
idocaine solution) was administered. Six-French hydro-
hilic sheaths (Terumo, Inc., Tokyo, Japan) were used, and
ll patients received 100 g of nitroglycerin and 2.5 mg of
verapamil through the radial sheath immediately after in-
sertion as well as heparin bolus 40 U/kg intravenously. The
choice of guidewires and catheters was made by the opera-
tors. To avoid placing 7-F sheaths for more complex
procedures requiring larger bore catheters, sheathless guides
were employed (ASAHI Sheath-less Eaucath PTCA Guid-
ing Catheter, Vascular Perspectives, Ltd., Cheadle, United
Kingdom) when needed. Additional devices and intracoro-
nary modalities, including intravascular ultrasound and pres-
sure wire, were used freely by the operators, according to their
judgment. Post-procedural hemostasis was applied by placing a
wrist clamp device (TR Band, Terumo Medical Corporation,
Somerset, New Jersey) for approximately 180 min.
Patient-perceived discomfort was assessed in the morning
after the procedure, with a visual analogue scale (VAS),
whereby the patient graded the discomfort on a scale of 0 to
100 (0 corresponding to “no discomfort” and 100 to
“extreme pain and discomfort”). The patients were followed
during their hospital stay and interviewed by phone contact
or on a clinic visit at 30 days from the index procedure.
The primary endpoint of this study was the incidence of
spasm during the procedure. It was identified by appearance
of marked resistance to the movement of or inability to
further advance catheters, with or without accompanying
forearm pain reported by the patient, and was confirmed
arteriographically as severe constriction of the radial artery
lumen. Secondary endpoints were Thrombolysis In Myo-
cardial Infarction major bleeding during hospital stay,
patient-reported procedure-related discomfort (VAS score),
and a 30-day safety composite of all-cause mortality or
repeat hospital stay for any cause.
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269All events and complications were studied and adjudi-
cated by a 3-member committee who were blinded as to
patient randomization and were not involved in patient care.
The same committee reviewed the arteriograms of radial
arteries in the cases of spasm to ensure adequate angio-
graphic documentation of spasm.
Statistical analysis. Assuming a 10% rate of spasm in control
subjects, to detect a decrease of 40%, with a probability of
90%, 965 patients were needed/randomization group (in a
1:1 allocation ratio) at an alpha level of 0.05. Continuous
variables are expressed as mean  SD. Student t test was
used for comparisons of continuous variables. Categorical
variables were expressed as percentages and counts and
compared with the chi-square test. Binary logistic regression
analysis was applied to test independent associations be-
tween various parameters and the occurrence of spasm. The
SPSS software package was used (version 16, SPSS, Inc.,
Chicago, Illinois). Two-sided p values 0.05 were consid-
red as indicative of statistical significance.
esults
The study included 2,013 patients (29.1% female; age
64.5  8.4 years), randomized into 2 groups (1,007 in the
treatment group and 1,006 control subjects) (Fig. 1). Base-
line population characteristics, by randomization group and
overall, are presented in Table 1. The 2 study arms were well
alanced, without significant differences with regard to
emographic data and procedural parameters. Peri-
rocedural mortality was low and similar in the 2 groups
3 cases in the treatment group, and 4 in the control group;
verall 0.35%). No cases of respiratory depression requiring
echanical respiratory support were recorded. Mild allergic
eactions (skin rash and pruritus) shortly after fentanyl
nd midazolam infusion (before contrast medium was
njected) were observed in 11 patients of the treatment
roup (1.1%). Eight patients of the treatment group
0.8%) had a paradoxical reaction to midazolam (agita-
ion, restlessness). An opioid and/or midazolam had to be
dministered in 41 patients of the control group (4.1%)
uring the procedure.
Primary outcome measure. Spasm occurred in 26 patients of
he treatment group (2.6%) versus 83 in the control group
8.3%; p  0.001; odds ratio [OR]: 0.29, 95% confidence
nterval [CI]: 0.18 to 0.47). The relative risk reduction was
8.7%, and the number needed to treat to avoid 1 incidence
f spasm was 18 (17.6; 95% CI: 12.9 to 26.6).
As a result, the access site crossover rate was 34% lower in
he treatment group: 9.9% versus 15.0% (OR: 0.62, 95% CI:
.48 to 0.82; p 0.001). Patients with spasm had an OR of
7.9 (95% CI: 28.7 to 79.8) for access crossover compared
ith those without spasm (p  0.001). In 81.7% of patients
ith radial artery spasm the operator had to forgo theransradial route. Accordingly, spasm was the most frequent pause for access site crossover, being responsible for 35.5%
f crossovers, followed by (in decreasing order of frequency):
xcessively acute angulation between the innominate artery
nd the aortic arch, severe tortuosity and/or anatomic
ariations of the upper limb arteries (including high takeoff
f the radial artery and arteria lusoria), poor guide support,
adial artery complication (e.g., radial artery perforation or
issection).
Overall, the incidence of spasm was 5.4%. Patients with
horter stature and lower body mass index were more prone
o spasm. Female sex and smoking were also predisposing
actors. Spasm was more frequent in patients undergoing
ombined coronary angiography and PCI procedures (as
pposed to PCI only) and was positively associated with the
umber of catheters used/procedure, the duration of the
Figure 1. Study Flow Chart
Eligible patients were randomized before the procedure but were not
ﬁnally included if a percutaneous coronary intervention (PCI) was not per-
formed. Analysis was by intent-to-treat: all randomized patients who under-
went a coronary intervention were analyzed in their randomization group.
CAA  coronary artery angiography.rocedure, and the administered contrast volume (Table 2).
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270Secondary analyses. Self-reported patient discomfort was
significantly lower in the treatment group: 18.8  12.5
oints (of the 100-point maximum VAS score) versus 27.4 
7.4 points in the control group. Spasm was, expectedly,
trongly associated with higher patient discomfort, with
atients reporting almost double VAS scores if spasm
ccurred (55.7  13.8 vs. 21.2  13.6; p  0.001).
By contrast, no significant differences were observed
ith regard to the secondary composite safety endpoint
30-day death or repeat hospital stay for any cause),
hich was reached in 46 patients of the treatment group
4.6%) versus 45 (4.5%) of control subjects (OR: 1.02,
Table 1. Population Characteristics
Overall
(n  2,013)
Demographic data
Age (yrs) 64.9 8.3
Female sex 606 (30.1%)
BMI (kg/m2) 27.0 3.3
Diabetes 652 (32.4%)
Hypertension 819 (40.7%)
Smoking 692 (34.4%)
Dyslipidemia 1,063 (52.8%)
Peripheral artery disease 329 (16.3%)
Renal dysfunction 459 (22.8%)
Previous radial artery
catheterization
211 (10.5%)
Procedural parameters
CAA and ad hoc PCI* 965 (47.9%)
Additional modalities
FFR 302 (15.0%)
IVUS 217 (10.8%)
Values are mean SD, or n(%).
*As opposed to PCI alone.
BMI bodymass index; CAA coronary artery angiography; FFR
coronary intervention.
Table 2. Potential Univariate Spasm Correlates
No Spasm
(n  1,904)
Spasm
(n  109)
Univariate
p Value
Age (yrs) 64.8 8.1 66.2 10.8 0.175
Female sex 533 (28.0%) 73 (67.0%) 0.001
BMI (kg/m2) 27.1 3.3 25.6 2.7 0.001
Height (cm) 172.3 6.6 162.7 6.3 0.001
Number of catheters 2.4 0.9 3.7 0.8 0.001
Procedure duration (min) 63.5 15.1 80.7 23 0.001
Contrast volume (ml) 367.7 110.0 471.9 130.3 0.001
Procedure type (CAA and ad hoc PCI) 875 (46.0%) 90 (82.6%) 0.001
Active smoking status 634 (33.3%) 59 (54.1%) 0.001
Renal dysfunction* 441 (23.2%) 18 (16.5%) 0.108
Values are mean SD, or n(%).
*Estimated (Cockroft-Gault) glomerular filtration rate60 ml/min/1.73 m2.Abbreviations as in Table 1.5% CI: 0.67 to 1.56; p  0.918). There was also no
significant difference between the 2 groups in terms of
Thrombolysis In Myocardial Infarction major in-hospital
bleeding (1.1% in the treatment group vs. 1.0% in control
subjects; p  0.812).
Multivariate analysis. In the multivariate analysis, where the
occurrence of spasm was entered as the dependent variable,
the independent association of treatment with the incidence
of spasm was tested after accounting for sex, height, body
mass index, smoking habit, number of catheters used/
procedure, procedure type (angiogram plus PCI or PCI
alone), and procedure duration. The results (Fig. 2) denote
that the administration of sedation-analgesia was indepen-
dently associated with a marked reduction in the incidence
of spasm (multivariate hazard ratio: 0.140, 95% CI: 0.073 to
0.271; p  0.001).
Discussion
The principal finding of this prospective randomized study
is the reduction in the incidence of radial artery spasm by
administration of opioid analgesia combined with sedation
during transradial PCI procedures. This resulted in signif-
icant decrease in access site crossover rate and less patient
discomfort. Moderate doses of the 2 drugs were used,
without titration according to the level of sedation of the
patient.
Transradial arterial access for left heart catheterization
tment Group
n  1,007)
Control Group
(n  1,006) p Value
64.5 8.2 65.2 8.3 0.081
15 (31.3%) 291 (28.9%) 0.250
26.9 3.0 27.0 3.4 0.667
10 (30.8%) 342 (34.0%) 0.124
06 (40.3%) 413 (41.1%) 0.737
65 (36.2%) 327 (32.5%) 0.077
31 (52.7%) 532 (52.9%) 0.946
62 (16.1) 167 (16.6%) 0.756
40 (23.8%) 219 (21.8%) 0.270
96 (9.5%) 115 (11.4%) 0.164
68 (46.5%) 497 (49.4%) 0.188
56 (15.5%) 146 (14.5%) 0.209
08 (10.7%) 109 (10.8%) 0.904
al flow reserve; IVUS intravascular ultrasound; PCI percutaneousTrea
(
3
3
4
3
5
1
2
4
1
1
fractionand PCI is increasingly being used in Europe and the
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271United States for emergent and elective procedures, in lieu
of the femoral approach (1,8). Lower rates of access-related
complications, more timely patient mobilization, shorter
hospital stays, and less patient discomfort are some of the
advantages of the transradial access route (1,4,5,9). How-
ever, increased rate of access site crossover has been reported
when the transradial access is used (1,5), with radial artery
spasm being a major contributor to this effect. The reported
frequency of spasm in transradial procedures shows consid-
erable variation in the published data, ranging from as low
as 4% to higher than 20% (7,9–13). The manifestation of
spasm during a procedure is a troublesome complication; as
a result, preventive measures have been devised, most
commonly including administration of a “vasodilator cock-
tail” after insertion of the radial artery sheath. This cocktail
usually includes verapamil and/or a nitrate derivative
(10,11,14,15), whereas a number of other agents have also
been tried with varying results (16,17).
Using sedation as a means to reduce spasm seems to be a
plausible hypothesis, because spasm can be triggered by
procedure-related stress and pain. Pre-medication with—
usually oral—benzodiazepines is being used in several
catheterization laboratories in hopes of reducing spasm, but
the effect of routine administration of sedation and analgesia
on the incidence of radial artery spasm has not been
Figure 2. Plot of Independent Effect Estimates on Spasm Incidence of Vari
Forest graph illustrating the results of the multivariate analysis. Assignment to
“procedure type” refers to whether angiography and percutaneous coronary insystematically evaluated (7).The effect of relatively low doses of an opioid and a
benzodiazepine on the appearance of radial artery spasm
seen in the present study has a sound pharmacobiological
basis. Their sedative and analgesic action—along with the
accompanying dissociative effect—could, in their own right,
explain their impact on spasm incidence, but it is also true
that they have direct vasoactive effects. Gursoy et al. (18)
studied the vasodilatory effect of several opioids on the
isolated radial artery and reported that all the tested agents
produced concentration-dependent and endothelium-
independent relaxation in human radial artery rings, with
meperidine and fentanyl being more potent relaxant agents
than morphine and remifentanil. The vasodilatory effects of
fentanyl have also been demonstrated in human vein exper-
imental models (19). Benzodiazepine-induced vasodilation
is also a well-documented effect. Colussi et al. (20) showed
that low concentrations of midazolam induce vasodilation
via an endothelium-dependent mechanism that does not
involve nitric oxide production, whereas high concentra-
tions of midazolam induce vasodilation via an endothelium-
independent mechanism. Midazolam has been shown to
lead to hyperpolarization of human smooth muscle cells,
probably through activation of potassium channels, resulting
in vasorelaxation (21), while it attenuates the vasoconstric-
tive response to adrenergic stimuli (22), which might be a
pasm Correlates
eatment group was the most important negative predictor of spasm. Note:
tion (PCI) were performed within the same session as opposed to PCI alone.ous S
the trparticularly relevant action in the setting of adrenergic
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272overactivation circumstances, such as the stress-inducing
situation of a PCI procedure.
By contrast, although the routine administration of opi-
oid analgesia and sedation in patients undergoing elective
PCI led to a significant reduction in spasm occurrence, the
effect of this practice on safety endpoints, including major
bleeding and 30-day death or repeat hospital stay, was
neutral. This is reassuring as far as the safety of the studied
treatment is concerned but also indicates that the reduction
of spasm is not translated into better outcomes. However,
this was to be expected, because the population of the study
was a generally low-risk population (elective procedures)
with low expected in-hospital and short-term adverse out-
come rates. As a result, an intervention such as that
described in the present report would not be expected
to—and indeed was not found to—have a significant
impact on hard endpoints. Consequently, the main merit of
the proposed strategy lies in the prevention of radial artery
spasm, which in itself is a valid target, because when it
happens, it complicates and usually prolongs the procedure,
frustrates the interventionalist, increases the possibility of
subsequent radial artery closure (23), aggravates patient
discomfort, and essentially nullifies the advantages of the
transradial approach. Of note, in this large series of patients
no serious adverse events related to the administration of
fentanyl and midazolam were observed.
Study limitations. Spasm cannot always be defined with
objectivity, and different definitions have been proposed in
the past (12,13). The definition used in the present study is
quite restrictive, because it requires angiographic confirma-
tion, but it has the advantage of objectivity. Furthermore,
because there is no reason to believe that spasm was
reported in a different way between the 2 treatment arms,
the issue of definition of spasm should not be of import for
the conclusions of this study. In addition, it should be noted
that some patient subgroups were excluded (see Methods),
and as a result, the study findings might not be applicable in
these patient subsets (although some of these patient sub-
groups might not be candidates for sedation anyway). The
use of a specific sedation protocol implies that these findings
might not necessarily apply to other sedative medications.
However, the studied drugs are widely used throughout the
world in catheterization laboratories. Finally, it should be
taken into account that operators in this trial were all very
experienced in transradial procedures, and the need for
patient sedation might be greater among novice or less
experienced operators.
Conclusions
Routine administration of moderate doses of fentanyl and
midazolam during transradial interventional procedures is
associated with a substantial reduction in the rate of spasm,
the need for access site crossover, and the level of patientdiscomfort. No differences were found as far as secondary
safety endpoints were concerned. These results suggest that
routine administration of moderate procedural sedation
during transradial procedures could be useful in everyday
practice. By contrast, although the relative risk reduction
was substantial, the number needed to treat was relatively
high, obviously due to the relatively low overall incidence of
spasm. These observations indicate that a focused use of this
option in catheterization laboratories where conscious seda-
tion is not routinely administered (i.e., administration of
fentanyl-midazolam only in cases of anticipated increased
complexity of a procedure or in patients with risk factors for
spasm) might also be a reasonable recommendation.
Reprint requests and correspondence: Dr. Georgios Giannopou-
los, Athens General Hospital “G. Gennimatas”, Department of
Cardiology, Cardiac Catheterization Laboratory, 154 Mesogeion
Avenue, 11527 Athens, Greece. E-mail: ggiann@med.uoa.gr.
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